Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
- PMID: 2270743
- DOI: 10.1111/j.1600-0404.1990.tb04483.x
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
Abstract
The average annual incidence of definite and probable MS in Gothenburg was re-investigated. For 1950-1954, 1955-1959 and 1960-1964 it was 4.2, 4.2 and 4.3/100,000/year. For the five-year periods between 1974 and 1988 it was 3.0, 2.7 and 2.0/100,000/year. If possible MS was included, the corresponding incidence for 1950-1964 was 5.2, 5.3 and 5.1, and for 1974-1988 it was 3.9, 3.9 and 4.3/100,000/year. Neurological methods and diagnostic criteria were constant throughout the period. The 1950-1964 incidence was based on personally investigated cases, while the 1974-1988 incidence was based partly on review of Gothenburg neurology records. It is concluded that there has been a significant decrease in the incidence of MS in this area. However, the notified decrease may partly be explained by alterations in the case ascertainment procedure. Since the Swedish measles vaccination program started in 1971, the occurrence of measles has been declining and has practically ceased during the 1980s. The time when a possible influence of mass vaccinations against childhood diseases on MS incidence can be monitored is discussed.
Similar articles
-
Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations.Acta Neurol Scand. 2009 May;119(5):313-20. doi: 10.1111/j.1600-0404.2008.01131.x. Epub 2008 Dec 22. Acta Neurol Scand. 2009. PMID: 19154535
-
Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations.Acta Neurol Scand. 1996 Feb-Mar;93(2-3):104-9. doi: 10.1111/j.1600-0404.1996.tb00183.x. Acta Neurol Scand. 1996. PMID: 8741127
-
Elimination of childhood diseases: possible influence on the incidence of multiple sclerosis soon detectable.Neuroepidemiology. 2002 Nov-Dec;21(6):306-9. doi: 10.1159/000065529. Neuroepidemiology. 2002. PMID: 12411735 No abstract available.
-
From the Gothenburg cohort to the Swedish multiple sclerosis registry.Acta Neurol Scand Suppl. 2012;(195):13-9. doi: 10.1111/ane.12023. Acta Neurol Scand Suppl. 2012. PMID: 23278651 Review.
-
Gender differences in multiple sclerosis epidemiology and treatment response.Dan Med J. 2016 Mar;63(3):B5212. Dan Med J. 2016. PMID: 26931196 Review.
Cited by
-
HLA and prognosis in multiple sclerosis.J Neurol. 1994 May;241(6):385-90. doi: 10.1007/BF02033356. J Neurol. 1994. PMID: 7931434
-
Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern Sweden.Mult Scler Int. 2022 Mar 19;2022:5464370. doi: 10.1155/2022/5464370. eCollection 2022. Mult Scler Int. 2022. PMID: 35345609 Free PMC article.
-
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128. BMC Neurol. 2013. PMID: 24070256 Free PMC article.
-
Surveying multiple sclerosis in the United Kingdom.J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2-6. doi: 10.1136/jnnp.58.1.2. J Neurol Neurosurg Psychiatry. 1995. PMID: 7823061 Free PMC article. No abstract available.
-
Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis.Front Mol Neurosci. 2022 Nov 4;15:1019877. doi: 10.3389/fnmol.2022.1019877. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36407764 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical